Optimizing market access

Market access strategy is complex, dynamic, and constantly evolving. Over the last several years, payers have increasingly used formulary tiering as one tool to help control and manage market access. With intensifying public pressure to reduce drug spending, this trend is likely to continue.

Optimizing market access requires an understanding of how payers might leverage tools differently among therapeutic or disease areas or across segments. Market access leaders should make decisions around what strategies to prioritize and implement in this context.

In the report, we explore several different strategies drug manufacturers can leverage to influence or make the best of formulary positioning.